These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 37296188

  • 1. Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome.
    Furgała A, Ciesielczyk K, Przybylska-Feluś M, Jabłoński K, Gil K, Zwolińska-Wcisło M.
    Sci Rep; 2023 Jun 09; 13(1):9420. PubMed ID: 37296188
    [Abstract] [Full Text] [Related]

  • 2. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H, Yan Y, Shi R, Lin Z, Wang M, Lin L.
    Digestion; 2008 Jun 09; 78(2-3):72-6. PubMed ID: 18948690
    [Abstract] [Full Text] [Related]

  • 3. Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients.
    Mazur M, Furgała A, Jabłoński K, Mach T, Thor P.
    Med Sci Monit; 2012 Aug 09; 18(8):CR493-499. PubMed ID: 22847198
    [Abstract] [Full Text] [Related]

  • 4. Proximal and distal gut hormone secretion in irritable bowel syndrome.
    Van Der Veek PP, Biemond I, Masclee AA.
    Scand J Gastroenterol; 2006 Feb 09; 41(2):170-7. PubMed ID: 16484122
    [Abstract] [Full Text] [Related]

  • 5. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls.
    van der Schaar PJ, van Hoboken E, Ludidi S, Masclee AA.
    Colorectal Dis; 2013 Jan 09; 15(1):e29-34. PubMed ID: 23006632
    [Abstract] [Full Text] [Related]

  • 6. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K, Konturek SJ, Sodowski M, Wylezol M, Kuka D, Sowa P, Adamczyk-Sowa M, Kukla M, Berdowska A, Rehfeld JF, Bielanski W, Brzozowski T.
    J Physiol Pharmacol; 2007 Mar 09; 58 Suppl 1():13-35. PubMed ID: 17443025
    [Abstract] [Full Text] [Related]

  • 7. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
    Gonlachanvit S, Mahayosnond A, Kullavanijaya P.
    Neurogastroenterol Motil; 2009 Jan 09; 21(1):23-32. PubMed ID: 18647268
    [Abstract] [Full Text] [Related]

  • 8. Inhibited postprandial retrograde cyclic motor pattern in the distal colon of patients with diarrhea-predominant irritable bowel syndrome.
    Wiklendt L, Mohd Rosli R, Kumar R, Paskaranandavadivel N, Bampton PA, Maslen L, Costa M, Brookes SJ, O'Grady G, Dinning PG.
    Am J Physiol Gastrointest Liver Physiol; 2023 Jul 01; 325(1):G62-G79. PubMed ID: 37162180
    [Abstract] [Full Text] [Related]

  • 9. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S.
    Obes Surg; 2012 Jul 01; 22(7):1084-96. PubMed ID: 22359255
    [Abstract] [Full Text] [Related]

  • 10. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
    Simrén M, Abrahamsson H, Björnsson ES.
    Gut; 2001 Jan 01; 48(1):20-7. PubMed ID: 11115818
    [Abstract] [Full Text] [Related]

  • 11. [Role of gut hormones in irritable bowel syndrome].
    Morise K, Furusawa A, Yamamoto H, Saito H.
    Nihon Rinsho; 1992 Nov 01; 50(11):2697-702. PubMed ID: 1287245
    [Abstract] [Full Text] [Related]

  • 12. The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals.
    Monem SMA, Elbadrawy EG, Shalaby SM, Hendawy DM, Hassan SM, Almonem NA.
    J Med Life; 2022 Dec 01; 15(12):1525-1531. PubMed ID: 36762339
    [Abstract] [Full Text] [Related]

  • 13. A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.
    Roth B, Myllyvainio J, D'Amato M, Larsson E, Ohlsson B.
    Nutrients; 2022 Apr 19; 14(9):. PubMed ID: 35565656
    [Abstract] [Full Text] [Related]

  • 14. Are gut peptides responsible for the irritable bowel syndrome (IBS)?
    Sjölund K, Ekman R.
    Scand J Gastroenterol Suppl; 1987 Apr 19; 130():15-20. PubMed ID: 3477012
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients.
    Mazur M, Furgała A, Jabłoński K, Madroszkiewicz D, Ciećko-Michalska I, Bugajski A, Thor PJ.
    J Physiol Pharmacol; 2007 Aug 19; 58 Suppl 3():131-9. PubMed ID: 17901589
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C, Pelosini I.
    Can J Gastroenterol; 1999 Mar 19; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.